7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Alto Neuroscience Inc
(NYSE:ANRO) 

ANRO stock logo

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatone...

Founded: 2019
CEO / Founder: Amit Etkin 
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
No extra charts and metrics for this ticker.